Day: May 5, 2022

Biologic Product

[FDA] FDA: A biologic product is any virus, serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product applicable to the

Read More »

Approval Letter

[FDA] A written communication to an applicant from FDA approving an application or an abbreviated application. Source: 21 CFR 314.3(b)

Read More »

Applicant

“A pharmaceutical company or its agent that is submitting information in support of an application.” Source: Harmonised Technical Guidance for eCTD Submissions in the EU

Read More »

Annual Report

[FDA] Post-NDA report (submission) providing the FDA with a summary of new research data, distribution information and labeling changes plus certain other information form manufacturers.

Read More »

Annotated ECG waveform data

“Annotated ECG waveform data are raw voltage-versus-time data comprising the electrocardiogram recording, to which have been attached the identification of various intervals or other features.”

Read More »

Analysis Datasets

Analysis datasets are datasets created to support results presented in study reports, the ISS and the ISE and to support other analyses that enable a

Read More »

Analysis Data Model (AdAM)

ADaM defines dataset and metadata standards that support efficient generation, replication, and review of clinical trial statistical analyses, and traceability among analysis results, analysis data,

Read More »

Amendment

“[FDA] Information submitted to a pending submission, including additional information or reanalysis of data previously submitted to clarify, revise or modify the application as originally

Read More »

Adjuvant

An ingredient in a medicine that increases or modifies the activity of the other ingredients. Adjuvants are often included in vaccines to enhance the body’s

Read More »

Drug Substance (DS)

[FDA] [An] active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease

Read More »

Abridged Application

Abridged applications are applications where, subject to certain conditions, the applicant is not required to provide the results of pharmacological and toxicological tests or the

Read More »

Adverse Drug Reaction (ADR)

Single or repeated drug administration as well as combination of different drugs administration can cause injury to patients. Adverse Drug Reaction: The detection, assessment, understanding

Read More »

Signal Detection

Signal detection process is a set of activities performed to determine whether, based on an examination of individual case safety reports (ICSRs), aggregated data from

Read More »

Adverse Event (AE)

Any untoward medical occurrence, unintended disease or injury, or any untoward clinical signs (including an abnormal laboratory finding) in subjects, users, or other persons whether

Read More »

Register to access to our exclusive library!

Highlight Post

Recent Posts